<DOC>
	<DOC>NCT00384072</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of 20 mg of bazedoxifene in comparison to placebo on bone mineral density after 6 months of therapy in a population of postmenopausal Asian women.</brief_summary>
	<brief_title>Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>1. Generally healthy Asian women 45 years of age or older who are at least 1 year postmenopausal 2. Subjects must qualify for one of the following categories (a or b): 1. Greater than 1 year but less than 5 years postmenopausal with at least one of the ospeoporosis risk factors 2. Equal or greater than 5 years postmenopausal with BMD Tscore at lumbar spine or femoral neck between 1 and 2.5 (values of 1 and 2.5 are acceptable) with at least one osteoporosis risk factor 1. One (1) or more osteoporotic vertebral fractures (T4 L4) 2. BMD Tscore at the lumbar spine or femoral neck less than 2.5 3. Past history or active nontraumatic venous thromboembolic events, including deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>postmenopausal</keyword>
	<keyword>women</keyword>
	<keyword>SERM</keyword>
	<keyword>osteoporosis</keyword>
</DOC>